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Background: The opioid antagonist agent naloxone hydrochloride (NLX) is a drug that has high affinity for opiate
receptors but do not activate these receptors. Owing to the role of this drug to block the effects of exogenous
administered opioids and endogenous released endorphians we can deduce the importance of developing
sensitive analytical methods for detection of such drug. In the present study gold nanoparticles (AuNPs) was
employed for enhancing the chemiluminescence (CL) signals arising from luminol-ferricyanide reaction in the
presence of naloxone hydrochloride using sequential injection chemiluminescence analysis (SIA).
Method: In the present study gold nanoparticles (AuNPs) was employed for enhancing the chemiluminescence
(CL) signals arising from luminol-ferricyanide reaction in the presence of naloxone hydrochloride using sequential
injection chemiluminescence analysis (SIA).
Results: The developed method was examined under optimum experimental conditions and the obtained results
revealed a linear relationship between the relative CL intensity and the investigated drug at a concentration
range of 1.0×10−9-1.0×10−2 mol L−1, (r = 0.9993, n=9) with detection and quantification limits of 1.6×10−11 and
1.0×10−9 mol L−1, respectively. The relative standard deviation was 0.9%.
Conclusion: The proposed method was employed for the determination of the investigated drug in bulk powder,
its pharmaceutical dosage forms and biological fluids. The interference of some metals and amino acids on the CL
intensity was investigated. Also the interference of some related pharmacological action drugs was tested. The
obtained results of the developed method were statistically treated and compared with those obtained from other
reported methods.
Keywords: Chemiluminescence, Gold nanoparticles, Naloxone hydrochloride, Luminol, Potassium ferricyanide,
Pharmaceutical dosage forms, Biological fluidsBackground
Opioid antagonist such as a naloxone hydrochloride
(NLX) is considered as an essential tool in scientific
evaluations of opiates and opiate receptors [1]. It is
clinically used after opioid overdoses or opioid anes-
thesia to restore spontaneous ventilation in patients
who breathe inadequately. Also, it can reduce opioid-
induced nausea and vomiting, pruritus, urinary reten-
tion, rigidity etc. [2].* Correspondence: star2000star@gmail.com
1Department of Chemistry, College of Science, King Saud University, P.O. Box
22452, Riyadh 11495, Saudi Arabia
2Permanent address: General Administrative of Medical Affairs, Zagazig
University, Zagazig, Egypt
© 2015 Alarfaj and El-Tohamy; licensee Sprin
Commons Attribution License (http://creative
reproduction in any medium, provided the o
Dedication waiver (http://creativecommons.o
unless otherwise stated.Naloxone hydrochloride (Figure 1) is a drug that be-
longs to a group of medications known as narcotic an-
tagonists. They are used to treat overdoses of narcotic
medications (such as morphine, codeine, and oxycodone).
It works by reversing the side effects of the narcotics, such
as sedation and decreased breathing rate [2]. The lite-
rature survey reveals that several methods have been
reported for determination of NLX mainly including
high performance liquid chromatography [3-7], high
performance liquid chromatography coupled with mass
spectrometry [8-11], gas–liquid chromatography [12],
chemiluminescence [13-15].ger. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
riginal work is properly credited. The Creative Commons Public Domain
rg/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Chemical structure of naloxone hydrochloride.
Figure 2 Histogram of different kinds of oxidants on CL
intensity of AuNPs-luminol system.
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chemical reactions that emit light in the visible and in-
frared region without any need for excitation source
[16]. The chemists were categorized the chemilumines-
cence to three types. Reactions involve highly oxidizied
peroxide species, biochemiluminescence reactions which
occure in living organisms and electrogenerated chemilu-
minescence reactions that used the electrical current to
intiate the emitting light. Owing to the optical properties
of the nanoparticles such as silver or gold nanoparticles,
the researchers have been attended to use nanotechnology
in many analytical methods, in particular the use of silver
or gold nanoparticles to enhance various chemical chemi-
luminescence reactions [17,18]. They were found that the
use of silver or gold nanoparticles in nanoscale size in-
creased the intensity and the duration of the produced
light. Additionally, due to the chemical stability and the
high resistance of surface oxidation of gold nanoparti-
cles rather than silver nanoparticles, the employing of
gold nanoparticles in enhancing the chemiluminescence
reactions were considered the point of view for many
researchers [19].
The objective of the present study is to develop new,
simple and highly sensitive sequential injection chemi-
luminescence analysis (SIA-CL) method using gold
nanoparticles-luminol-ferricyanide system to determine
naloxone hydrochloride an opioid antagonist receptor
drug. The proposed method is more simple, less time and
reagents consuming, highly sensitive with lower limit of
detection than other chromatographic methods. The de-
veloped method conditionally optimized and employed
for the detection of the investigated drug in bulk powder,
its pharmaceutical dosage forms and biological fluids.
Results and discussion
To select the optimum conditions for CL analysis various
preliminary studies should be carried out. These include
the selection of the oxidizing agent, the effect of alkaline
medium, effect of luminol and potassium ferricyanideconcentrations, effect of AuNPs concentration on the
CL intensity and optimization of aspirated volume of
reagents and samples, etc.
Selection of potassium ferricyanide as oxidizing agent
Various oxidants including potassium ferricyanide, potas-
sium permanganate, potassium periodate and hydrogen
peroxide were investigated to select the most suitable oxi-
dizing agents. No CL signals were detected by using po-
tassium permanganate or potassium periodate. While,
using hydrogen peroxide or potassium ferricyanide ex-
hibit CL signals. As shown in Figure 2 potassium ferri-
cyanide gave the higher CL intensity signal rather than
that of hydrogen peroxide. Therefore, luminol-potassium
ferricyanide-CL system was selected and the effect of
luminol and potassium ferricyanide concentration was
further investigated and optimized.
Effect of luminol and potassium ferricyanide
concentration
The effect of luminol and potassium ferricyanide con-
centrations on the CL signals was considered as one of
the most important factors which should be investigated.
Various concentration ranges of 1.0×10−6-1.0×10−1 mol L−1
of each luminol and potassium ferricyanide were tested.
The CL signals were recorded and it was found that the
CL signals were sharply increased in the presence of
5.0×10−4 mol L−1 of luminol and 1.0×10−2 mol L−1 of
potassium ferricyanide. Therefore, the subsequent ex-
perimental analysis was carried out using these concen-
trations as indicated in (Figure 3).
Effect of AuNPs concentration
The CL intensity of luminol-potassium ferricyanide can
be greatly affected by the concentration of AuNPs added
to the system. The influence of AuNPs concentration
was investigated over the concentration range 1.0×10−6-
1.0×10−1 mol L−1. The suitable concentration of AuNPs
was found to be 1.0×10−5 mol L−1 as shown in (Figure 4)
and hence was selected in further studies.
Figure 3 Effect of luminol and potassium ferricyanide
concentration on CL intensity, for luminol concentration (Au NPs
1.0×10−5 mol L−1 and potassium ferricyanide 1.0×10−2 mol L−1)
and for potassium ferricyanide concentration (Au NPs
1.0×10−5 mol L−1, luminol 5.0×10−4 mol L−1) and 1.0×10−3 mol L−1
naloxone hydrochloride.
Figure 5 Effect of sodium hydroxide, ammonium hydroxide,
sodium carbonate and sodium bicarbonate concentration on
CL intensity of luminol-potassium ferricyanide system (AuNPs
1.0×10−5 mol L−3, potassium ferricyanide 1.0×10−2 mol L−1,
luminol 5.0×10−4 mol L−1) and 1.0×10−3 mol L−1 naloxone
hydrochloride.
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Owing to the reaction of luminol-ferricyanide in CL sys-
tem should be optimized in of alkaline medium, four
kinds of alkaline media, including ammonium hydroxide,
sodium carbonate, sodium bicarbonate and sodium hy-
droxide in the range 1.0×10−5-1.0×10−1 mol L−1 were
investigated. It was found that a sharp CL signal was
obtained by using 1.0×10−2 mol L−1 sodium hydroxide.
While the CL signals were significantly decreased by using
the other three alkaline media, therefore 1.0×10−2 mol L−1
sodium hydroxide was used for preparation of luminol in
the developed CL method (Figure 5).
Optimization of aspirated volumes of sample and
reagents
For AIA detection the aspirated volume of sample and
reagents should be carefully optimized. FIAlab software
version 5.9.321 was used for computer control and auto-
matic optimization of the aspirated volume of both samplesFigure 4 Effect of AuNPs concentration on the CL signal of
luminol-potassium ferricyanide system (luminol 5.0×10−4 mol L−1,
potassium ferricyanide 1.0×10−2 mol L−1) and 1.0×10−3 mol L−1
naloxone hydrochloride.and reagents. The optimum aspirated volume for luminol,
AuNPs and potassium ferricyanide was 50, 50 and 30 μL,
respectively and 30 μL for NLX sample. The time for
complete cycle was extended to about 45 s. The flow rate
was tested in the range of 20–120 μL s−1. The optimum
flow rate was found to be 100 μL s−1 and was used for fur-
ther studies (Figure 6).SIA control program
The SIA control program was employed to perform all
calibration measurements and experimental analysis of
NLX. Also, the investigated drug was determined by
utilizing an SIA control program in standard form, its
pharmaceutical dosage forms and in biological fluids.
The typical program was presented in Table 1. Each
cycle was performed in 45 s and the throughput of
samples can be recorded as 80 h−1.Figure 6 The influence of flow rate on the relative CL intensity.
Conditions; 50 μL of 5.0×10−4 mol L−1 luminol; 50 μL of
1.0×10−5 AuNPs mol L−1, 30 μL of 1.0×10−2 mol L−1 ferricyanide
and 30 μL of 1.0×10−3 mol L−1 naloxone hydrochloride.
Table 1 The control program of AuNPs- luminol- potassium ferricyanide SIA-chemiluminescence detection of NLX
Device Command Parameter Action
‘Loop Start (♯) 1
Next sample Counter clockwise
Peristaltic pump Delay (s) % 50
Peristaltic pump off 25
Detector ON
Syringe pump Valve position IN
Syringe pump Set flow rate (μL s−1) 100
Syringe pump Aspirate (μL) 1500 Pump filled with carrier
Syringe pump Delay until done
Multiposition valve Set valve position 3
Syringe pump Set flow rate (μL s−1) 100
Syringe pump Aspirate (μL) 50 (Luminol 5.0×10−4 mol L−1)
Multiposition valve Set valve position 2
Syringe pump Set flow rate (μL s−1) 100
Syringe pump Aspirate (μL) 50 (Gold nanoparticles 1.0×10−5 mol L−1)
Multiposition valve Set valve position 5
Syringe pump Set flow rate (μL s−1) 100
Syringe pump Aspirate (μL) 30 Sample (NLX)
Syringe pump Delay until done
Multiposition valve Set valve position 4
Syringe pump Set flow rate (μL s−1) 100
Syringe pump Aspirate (μL) 30 (Potassium ferricyanide1.0×10−2mol L−1)
Syringe pump Delay until done
Multiposition valve Detector 7
Syringe pump Set flow rate (μL s−1) 100
PMT Start scan
Syringe pump Empty




Table 2 Performance data obtained from the
determination of NLX using AuNPs-luminol - potassium
ferricyanide system
Analytical characteristics Value
Linear range, mol L−1 1.0×10−9-1.0×10−2
Detection limit, mol L−1 1.6×10−11
Quantification limit, mol L−1 1.0×10−9
Intercept on the ordinate 317858
Slope 25214.6
% RSD (n=9) 0.9%
Correlation coefficient, r 0.9993
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The developed SIA-CL method was used for deter-
mination of NLX in its bulk powder and pharmaceut-
ical dosage forms. The enhancing effect of AuNPs on
luminol-ferricyanide system gave high sensitivity and
accurate results. As presented in Table 2 the results for
determination of NLX in pure bulk and its pharmaceutical
dosage form were 99.1±0.7 and 98.9±0.8 respectively. The
obtained results were statistically treated t-test and F-test
[20] and compared with those obtained from high per-
formance liquid chromatography reported method [3].
The results did not reveal any significant difference be-
tween them at 95% confidence level proving similar ac-
curacy and precision. The use of the SIA-CL technique
is less time consuming and cost effective for reagents
and samples and the developed method gave wide linear
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other reported methods.
Effect of foreign substances
To study the effect of foreign substances on the selecti-
vity of the proposed CL method for detection of NLX in
its pharmaceutical dosage forms and some exicpients
was investigated. Also, the influence of foreign substances
such as sugars, amino acids and some common cations,
the effect of related pharmacological active drugs were
tested. 1.0×10−3 mol L−1 of NLX was investigated by add-
ing an amount of foreign substances ≈ 1.0×10−1 mol L−1.
The mean peak heights were compared with those ob-
tained with 1.0×10−3 mol L−1 pure standard NLX. The tol-
erable level was defined as the amount of foreign species
that produces an error not exceeding 5% in determining
the investigated substance. The obtained results as indi-
cated in Table 3 gave good selectivity for determination of
the investigated NLX. It can be seen that there is no in-
fluence on the determination of NLX in pharmaceutical
dosage forms. While, for serum samples main possible
interference from ascorbic acid, uric acid, urea, heavy
metal ions such as Fe3+, Fe2+, Cd2+, Co2+, Cu2+, Al3+ and
Ni2+ was observed. These substances have a very import-
ant role in the vital activities in the body and may present
in the human serum, so we should study the influence of
such substances on the chemiluminescence analysis. We
found that the presence of such substances during the
analysis gave some interferences in the peaks hight. The
latter ions can be eliminated by the addition of EDTA.
After 1000 fold dilution the interference from such sub-
stances could be greatly minimized to negligible levels.
Also, the recorded results showed interference due to the
presence of some related pharmacological active drugs
such as nalbuphine hydrochloride and naltrexone hydro-
chloride in the determination of NLX.
Method validation
Method validation is the process used to confirm that
the analytical procedure employed for a specific test is




Na+, K+, Mg2+, Cl−, NO3
−, NH4
+, EDTA and SO4
2− 4.8×10−5
Glucose, sucrose, lactose, talc, starch, magnesium
stearate, citric acid
9.2×10−6
Uric acid, ascorbic acid and urea 5.6×10−2
Adrenaline, dopamine, cysteine, histamine, tyrosine,
glucosamine
8.4×10−5
Al3+, Cd2+, Co2+, Fe2+, Fe3+, Mn2+, Ni2+, and Cu2+ 2.6×10−1
Nalbuphine hydrochloride and naltroxone hydrochloride 1.5×10−1validation was carried out with respect to linearity, lower
limit of detection, quantification limit, accuracy, precision,
and robustness according to ICH guidelines [21].
Linearity
The proposed SIA-CL method using AuNPs-luminol-
ferricyanide system was successfully employed for deter-
mination of NLX. The linearity of the proposed method
was recorded by plotting signals as a function of the tested
drug concentrations. Nine standard solutions of NLX
were subjected to SIA-CL detection. The regression line
was calculated using the least square statistical method
and was found to be (r = 0.999). The results obtained
clarified that the proposed SIA-CL method exhibits linear
concentration ranges at 1.0×10−9-1.0×10−2 mol L−1.
Lower limit of detection LOD
The lower limit of detection of the proposed SIA-CL
method for determination of NL was evaluated using
signal-to-noise ratio. It was detected by The lower limit
of detection S/N=3 as the concentration of NLX has a
CL signal equals three times that of a blank signal. The
recorded signal showed the lower limit of detection
3.3×10−10 mol L−1.
Quantification limit
The quantification limit of NLX was determined by the
proposed AuNPs- luminol- ferricyanide SIA-CL method
using signal-to-noise ratio equal to 10. The evaluation
of quantification limits (N= 10 σ/S) was found to be
1.0 ×10−9 mol L−1.
Accuracy
The accuracy of the developed AuNPs-luminol-ferricyanide
SIA-CL method for determination of NLX was investigated
using standard addition method. The accuracy was calcu-
lated in terms of mean percentage recovery. The tested
NLX standard solutions were subjected to CL analysis and
the calculated % recovery was found to be 99.25±0.84.
Precision
The method precision of the proposed AuNPs- luminol-
ferricyanide SIA-CL method for determination of NLX
was evaluated using intra-day and inter-day terms. Nine
replicates were carried out in this study and the obtained
results were calculated as % RSD values. The precision
of the proposed SIA-CL method was found to be 0.7%
and 0.6% of intra- and inter-day, respectively as shown
in Table 4. The above % RSD value is less than 2% indi-
cating good precision.
Robustness
The robustness of the SIA-CL method for determination
of NLX was carried out by introducing a small change in
Table 4 The recovery studies of the proposed SIA-CL










9.0 8.99 99.9 8.97 99.7
8.3 8.27 99.6 8.24 99.3
8.0 7.97 99.6 7.92 99.0
7.0 6.95 99.3 6.92 98.9
6.0 5.94 99.0 5.91 98.5
5.0 4.92 98.4 4.96 99.2
4.0 3.92 98.0 3.97 99.3
3.0 2.94 98.0 2.99 99.7
2.0 1.99 99.5 1.96 98.0
Mean % ±SD 99.0±0.7 99.1±0.6
% RSD 0.7% 0.6%
*Values are mean of three determinations for intra and inter-day determination.
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and sample volumes were changed using 100±10 μL s−1,
50±5 μL and 30±5 μL, respectively. The calculated % re-
covery of the proposed method was 99.12±0.5%. The ob-
tained results were closely in agreement with those
obtained from standard drug solutions.
Analytical applications
The proposed SIA-CL method was employed for deter-
mination of NLX. It was evident from obtaining results
that it gave satisfactory results for the determination of
NLX in pure forms and its dosage forms Table 5. TheTable 5 Determination of NLX using AuNPs-luminol-potassium
and dosage forms in comparison with reported method [3]









9.0 8.99 99.9 9.0 9.00
8.0 7.98 99.8 8.0 7.88
7.0 6.99 99.9 7.0 6.99
6.0 5.96 99.3 6.0 5.95
5.0 4.99 99.8 5.0 4.99
4.0 3.95 98.8 4.0 3.99
3.0 2.98 99.3 3.0 2.98
2.0 2.00 100.0
Mean %±SD 99.6±0.4 99.5±0.5
n 8 7
Variance 0.16 0.25
% SE* 0.14 0.09
% RSD 0.40 0.50
t-test 0.72(2.179)** 0.39(2.201)**
F-test 2.25(4.15)** 1.44(4.21)**
*% SE= SD/√n; **Figures in parentheses are the tabulated values of t-and F-testes aobtained results were statistically treated t-test and F-test
[20] and compared with those obtained from high per-
formance liquid chromatography reported method [3].
The results did not reveal any significant difference be-
tween them at 95% confidence level proving similar ac-
curacy and precision. On the other hand, the proposed
method was employed to determine the investigated drug
in biological fluids such as human urine and serum as
shown in Table 6. The obtained results indicated wide lin-
ear concentration ranges and more simple and sensitive
than other reported methods. Also, it is less time consum-
ing and cost effective for reagents and samples.
Experimental
Materials and reagents
All reagents were of analytical grade and were used
without further purification. Distilled water was used
throughout the experiments. Pure grade of naloxone
hydrochloride 99.8% and Narcan® ampoules, each ampoule
(1 mL) claimed to contain 400 μg mL−1 naloxone hydro-
chloride were kindly supplied by Bristol Myer Squibb
Co., Egypt. 5.0×10−4 mol L−1 luminol (Sigma Chemical
Co.) stock solution was prepared in 100 mL of 1.0×10−2
mol L−1 sodium hydroxide (WinLab). Potassium ferri-
cyanide (WinLab) was used to prepare 1.0×10−2 mol L−1
solution by dissolving 0.33 g in 100 mL distilled water.
Gold nanoparticles 1.0×10−1 mol L−1 were purchased
from (Sigma-Aldrich -Germany). Urine samples were
obtained from healthy volunteers and serum samples
(Multi-Serum Normal, Randox Laboratories, UK) were
obtained from commercial sources.ferricyanide SIA-injection CL detection in pure samples
Reported method [3]





100.0 5.0 4.96 99.2
98.5 4.7 4.66 99.1
99.9 4.5 4.45 98.9
99.2 3.9 3.89 99.7
99.8 3.6 3.56 98.9







t 95% confidence limit [20].
Table 6 Determination of NLX using AuNPs-luminol-potassium ferricyanide SIA-injection CL detection in serum and urine
Serum samples Urine samples
Taken-log conc. Found-log conc. Recovery % Taken log conc. Found-log conc. Recovery %
9.0 8.94 99.3 9.0 9.00 100.0
8.0 7.99 99.9 8.0 7.99 99.8
7.0 6.96 99.4 7.0 6.95 99.3
6.0 5.98 99.7 6.0 5.87 97.8
5.0 4.96 99.2 5.0 4.96 99.2
4.0 3.93 98.3 4.0 3.94 98.5
3.0 2.97 99.0 3.0 2.99 99.7
Mean %±SD 99.3±0.5 99.2±0.8
n 7 7
Variance 0.25 0.64
% SE 0.19 0.30
% RSD 0.50 0.80
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The fluorimetric/chemiluminescence measurements were
carried out using an SIA system (FIAlab-3500 instrument,
USA). It comprises of a CAVRO XL 3000 syringe pump
volume 2.5 mL (Cavro Scientific Instrument Int., USA)
and Vici Valco Cheminer RT® 125–0718 eight-port mani-
folds. The detector used is UV-lamp equipped with lab-
made CL module and the photomultiplier tube voltage
was 320 V. The system was conneted with autosampler
model ALM 3200. Moreover, SIA- system involving a
holding coil (length 70 cm, i.d. 0.8 mm, PTFE tubing vol-
ume 1.2 mL). The recorded signals were PC controlled
and (FIAlab for windows version 5.9.321) software was
used for data acquisition.Preparation of samples
Standard drug solution
A stock standard NLX solution 1.0×10−1 mol L−1 was
prepared by dissolving 1.82 g of pure drug in 50 mL dis-
tilled water. Serial solutions were prepared daily by ap-
propriate dilution. The employed working solutions were
in the range of 1.0×10−10-1.0×10−1 mol L−1.Figure 7 Schematic diagram of SIA injection system for
chemiluminescence determination of naloxone hydrochloride;
carrier stream (water); reagent 1 (luminol 5.0×10−4 mol L−1);
reagent 2 (potassium ferricyanide 1.0×10−2 mol L−1); reagent 3
(Au NPs 1.0×10−5 mol L−1, sample (naloxone hydrochloride).Preparation of injection solution
The Contents of 10 Narcan® ampoules each containing
400 μg mL−1 aqueous NLX were mixed. 1 mL of the drug
solution was transferred into a 10-mL volumetric flask
and completed to volume with distilled water to obtain a
solution labeled to contain 1.0×10−3 mol L−1 NLX. The
working solutions were prepared by serial dilutions in
the range of 1.0×10−9-1.0×10−3 mol L−1. The proposed
SIA-CL method was employed to determine the investi-
gated drug in each concentration. The mean % recove-
ries were calculated using a calibration graph.Preparation of serum and urine solutions
The developed enhanced AuNPs-SIA-CL technique was
employed for determination of NLX in human serum
and urine. Spiking technique was used for the preparation
of human serum and urine samples. 1.0 mL of serum was
spiked with a NLX standard drug solution to contain
1.0×10−1 mol L−1 and deprotinated by adding 1.0 mL
acetonitrile. Then 0.1 mL of NaOH (0.1 mol L−1), 1.0 mL
of ZnSO4.7 H2O (5.0% w/v) were added, where most of
the interfering species (mainly proteins) were removed by
precipitation [22]. The prepared solution was centrifuged
at 2500 rpm for 5 min. The treated sample was diluted
with distilled water to obtain a concentration of NLX in
the range of 1.0×10−9-1.0×10−3 mol L−1. No further pre-
treatment was required for urine samples. AuNPs-SIA-CL
detection was employed and the peak heights of CL sig-
nals were recorded and the % recovery was calculated by
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the same concentration levels of the drug in the water.
Preparation of gold nanoparticles AuNPs solution
A standard solution of 1.0×10−1 mol L−1 AuNPs was
purchased from Sigma-Aldrich Co. Working solutions
were prepared by serial dilution using distilled water in
the range of 1.0×10−5-1.0×10−1 mol L−1 to select the
suitable concentration that gives the maximum SIA-CL
signal.
Procedure
All chemiluminescence measurements were introduced
under PC control to ensure precision, control the valves
and pump movements. To fill all lines of the system car-
rier solution was introduced at first to remove the air
bubbles, then the test solution and reagents were aspi-
rated as a mixture of of 50 μL of 5.0×10−4 moL L−1
luminol, 50 μL of 1.0×10−5 mol L−1 AuNPs, 30 μL sam-
ple solution and 30 μL of 1.0×10−2 mol L−1 potassium
ferricyanide through the relevant ports of the multiposi-
tion valve at flow rate 100 μL s−1 as shown in Figure 7.
The resulting emission of the reaction was monitored
using flowthrough cell of PMT. The recorded signals were
automatically calculated by (FIAlab® supported software,
Version 5.9.321). All measurements were carried out at
ambient temperature 25±1°C.
Calibration
The calibration curve was plotted under the optimum
conditions for determination of NLX. The graph related
the CL intensity vs. the concentration of testing drug so-
lutions was plotted at 9 experimental points. The mean
peak heights were obtained after triplicate sample aspir-
ation. Conventional linear regression was utilized for fit-
ting the curve.
Conclusion
A new sensitive and selective SIA-CL method for deter-
mination of NLX was developed. The developed method
was employed to determine the investigated drug using
the enhancement effect of AuNPs on luminol-potassium
ferricyanide system. The enhanced effect of AuNPs in
the presence of NLX was proportional to its concentra-
tion and the linear concentration range was found to be
1.0×10−9-1.0×10−2 mol L−1. The results obtained were
treated statically and revealed good agreements with ob-
tained from the reported method. The proposed method
was introduced to determine NLX in bulk powder, its
dosage forms and biological fluids.
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